Saturday, May 29, 2010
CCR Clinical Trials at NIH: Clinical Research: Search for Clinical Trials at NIH ovarian cancer Results = 5
Genetic screening of breast cancer patients and their families have identified a number of variants of unknown clinical significance in the breast cancer susceptibility genes, BRCA1 and BRCA2.
These results illustrate the need for improved methods for predicting functional ESEs and the potential consequences of sequence variants contained therein.
Note: the abstract does not provide a definition of 'patient navigator'
IMPLICATIONS FOR PRACTICE: Data describing the role of patient navigation in breast cancer will assist in better defining future direction for the breast navigation role. Ongoing research will better inform issues related to role definition, integration into clinical breast cancer care, impact on quality of life, cost-effectiveness, and sustainability.